Breadcrumbs
Home / News and events / Activotec expands customer support network..."We are the only European company with service and support teams that are exclusively focused on peptide synthesis instrumentation and services," noted Chris Littlewood, CEO of Activotec. "Because of this, Activotec is uniquely positioned to support customers with informed technical assistance enabling them to get the most from their peptide synthesiser". "As part of our commitment to customers - Activotec also maintains a large stock of key spare parts and instrument consumables for immediate shipment anywhere in the world. Customer requests and ideas for instrument improvement are implemented within weeks.''
Katalina Digleria, a scientist at the Institute of Molecular Medicine (Oxford, UK) commented "We have been very pleased with Activotec's support over the years for our peptide synthesiser, they always respond quickly and are very knowledgeable about the synthesiser and its applications".
About Activotec
Activotec is a developer and manufacturer of automated peptide synthesizers. The Activo-P11 peptide synthesizer is an easy to use and affordable instrument for synthesis of very high quality peptides on a scale from 0.05 to 1.0 mmole. For many years - Activotec's custom peptide facility has been providing customers around the world with the highest-quality peptides at competitive prices. Operating out of a modern peptide synthesis facility in the UK the company is able to provide with fast delivery times milligram (mg) to multiple grams of peptides at all required purity levels and with any modifications required. Particular expertise focuses on difficult-to-synthesise sequences, non-natural modifications, and the design and synthesis of highly effective peptide therapeutics. Activotec also has an extensive R&D programme based on the modification and production of peptides and proteins for therapeutic use. The Company has filed a number of patent applications based on various synthesis techniques. Further patents have been filed relating to the development of novel peptide-based products for the treatment of cancer, HIV and diabetes.
If you would like further information on Activotec custom peptide synthesis services or automated peptide synthesisers please contact the company on +44 (0)1223 260008 or email This e-mail address is being protected from spambots. You need JavaScript enabled to view it .